AEZS

Aeterna Zentaris Inc
3.74
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Aeterna Zentaris Inc AEZS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 3.74 07:00:26
Open Price Low Price High Price Close Price Prev Close
3.74
more quote information »

Recent News

Date Time Source Heading
2/07/20237:00IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone
2/06/20239:30IHNWFeaturedHempacco Pre-launches Snoop Dogg Brands at the Champs Trade Show in Las Vegas, February 8 - 11, Exhibiting with Death Row Vapes in Booth #1201
1/17/202308:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/17/202308:05GLOBEAeterna Zentaris Provides Business Update and Outlines Key..
1/10/202308:05GLOBEAeterna Zentaris to Present at the Virtual Investor 2023..
11/03/202208:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/03/202208:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/03/202208:05GLOBEAeterna Zentaris Reports Third Quarter 2022 Financial..
9/06/202206:15TRMNH.C. Wainwright Reaffirms Their Buy Rating on Aeterna..
8/29/202208:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/29/202208:00GLOBEAeterna Zentaris Set to Regain Full Rights to Macrilen™..
8/08/202206:26TRMNH.C. Wainwright Sticks to Its Buy Rating for Aeterna..
8/04/202215:34EDGARAmended Report of Foreign Issuer Pursuant to Rule 13a-16 or..
8/03/202217:30GLOBEAeterna Zentaris Reports Second Quarter 2022 Financial..
8/03/202217:28EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/26/202215:50EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/20/202203:59BNZGWhy Crypto-Related Companies Traded Higher; Here Are 72..
7/19/202216:53EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/19/202212:04BNZGThis Financial Services Stock Is Trading Higher By 50%, Here..
7/18/202217:29EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/18/202217:05GLOBEAeterna Zentaris Announces Effective Date of Share..
7/15/202216:15GLOBEAeterna Zentaris Announces Shareholder Approval of Share..
7/06/202216:05GLOBEAeterna Zentaris Announces Further Adjournment of..
6/21/202216:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/21/202216:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/21/202216:01GLOBEAeterna Zentaris Announces Results of Annual Meeting of..
6/13/202208:00GLOBEAeterna Zentaris Achieves Proof-of-Concept for the Treatment..
6/09/202208:00GLOBEAeterna Zentaris to Present at the JMP Securities Life..
5/31/202207:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/25/202208:00GLOBEAeterna Zentaris’ Licensing Partner, Consilient Health..
5/18/202208:00GLOBEAeterna Zentaris to Present at the H.C. Wainwright Global..
5/17/202215:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/16/202214:15EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/16/202208:00GLOBEAeterna Zentaris Announces Virtual 2022 Meeting of..
5/13/202206:05EDGARPost-effective Amendment to Registration Statement (pos Am)
5/12/202208:05GLOBEUpdate on Positive Pre-Clinical Results from AIM Biologicals..
5/11/202208:05GLOBEAeterna Zentaris Reports First Quarter 2022 Financial..
5/11/202206:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/25/202208:05GLOBEAeterna Zentaris Abstract Accepted for Presentation at..
4/20/202206:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/19/202208:05GLOBEAeterna Zentaris Secures New European Patent Related to Use..
4/12/202208:05GLOBEAeterna Zentaris to Participate at the Virtual Investor 2022..
4/11/202208:05GLOBEAeterna Zentaris Abstract Accepted for Presentation at 13th..
3/31/202216:11EDGARAmended Report of Foreign Issuer Pursuant to Rule 13a-16 or..
3/29/202208:47SEEKAeterna Zentaris GAAP EPS of -$0.02 in-line, revenue of $1M..
3/29/202208:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/29/202208:00GLOBEAeterna Zentaris Reports Fourth Quarter and Full Year 2021..
3/29/202206:16EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/29/202206:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/21/202209:11SEEKAeterna Zentaris pivotal growth hormone deficiency trial..
3/21/202208:05GLOBEAeterna Zentaris Provides Update on Ongoing Pivotal Phase 3..
3/11/202206:26TRMNH.C. Wainwright Reiterates Their Buy Rating on Aeterna..